English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 2872/3785 (76%)
造訪人次 : 3441111      線上人數 : 557
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於MUIR管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.meiho.edu.tw/ir/handle/987654321/2789


    題名: Evaluating the Effects of the Components of Metabolic Syndrome, Fatty LiverandLiverFunctiononChronic Hepatitis C: Data Analysis of Adult Health Examinations
    作者: Chen, Chien-Hua;Chen, Mei-Chia;Hsiao, Szu-Mei;Lin, Pi-Li;Sun, Chien-An;Chou, Yu-Ching;Yang, Tsan
    關鍵詞: metabolic syndrome;chronic hepatitis C;liver function;health examination
    日期: 2015-08-19
    上傳時間: 2015-08-24T03:00:11Z (UTC)
    摘要: Objective: The purpose of this study was to investigate the influential factors of chronichepatitis C.
    Methods: This was a cross-sectional study.Subjects aged 40 through 70, who received physical check-up from January 1, 2007 to December 31, 2011 in a hospital in central Taiwan, were included in this study. Among them, 200 cases had a diagnosis of chronic hepatitis C and 744 of them were free of hepatitis C. Physical data was obtained from health examinations and blood tests. Data were analyzed using SPSS for Windows, version 18.0. Results: The prevalence rate of metabolic syndrome (MetS)in participants with chronic hepatitis C was 23.3%. The prevalence of chronic hepatitis C in women and participants aged 40–55yearswas high (35.6% for women and 15.7% for men; 33.8% for participants aged 40–55yearsand 16.9% for participants aged 56–70years). Regarding composite factors for MetS, the prevalence of chronic hepatitis Cin participants with a raised fasting plasma glucose (FPG) or hypertensionwas higher than that of participants without chronic hepatitis C (35.2% vs. 16.6%and25.7% vs. 17.3%for hyperglycemiaandhypertension, respectively); the results were all statistically significant. Logistic regression analysis was preformed to predict the influential factors of chronichepatitis C. The results indicated that women and participants aged 40–55yearsexhibited a relatively higherrisk ofchronichepatitis C. In addition, participants with MetS, hyperglycemia, hypertension, or abnormal liver function exhibited a comparatively higherrisk of chronichepatitis C; the odds ratios for these participants were 1.72 (95% confidence interval [CI]= 1.10–2.70), 1.76 (95%CI = 1.08–2.89), 2.33 (95%CI = 1.61–3.37), and 2.40 (95%CI = 1.62–3.55), respectively.
    Conclusion: This study indicatedthat abnormal liver function, MetSand its composite factors were correlated with chronichepatitis C. Copyright © WJMMS, all rights reserved.
    顯示於類別:[健康事業管理系 ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    1031114Evaluating the Effects of Mets fatty liver and liver function on CHC.pdf366KbAdobe PDF1297檢視/開啟


    在MUIR中所有的資料項目都受到原著作權保護.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋